SMTL ID : 2weg.1

Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.10 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.93, H.95, E.105, H.118, T.197 Ligands: FBV.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.93, A:H.95, A:H.118

1 x FBV: 2-fluorobenzenesulfonamide

FBV.2: 12 residues within 4Å: Chain A: Q.91, H.93, H.95, H.118, V.120, V.141, L.196, T.197, T.198, W.207 Ligands: ZN.1, GOL.3 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:V.120 Hydrogen bonds: A:T.197, A:T.197 Halogen bonds: A:T.197

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 9 residues within 4Å: Chain A: N.61, H.63, A.64, N.66, Q.91, H.93, H.95, T.198 Ligands: FBV.2 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.61, A:N.66, A:Q.91 Water bridges: A:N.66, A:T.198

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, A.D. et al., Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem (2009)

Release Date

2009-11-10

Peptides

CARBONIC ANHYDRASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CARBONIC ANHYDRASE 2

Related Entries With Identical Sequence